| Trial | Title | Study Record Detail | Phase | Sponsor/Collaborator |
|---|---|---|---|---|
| FRF4998g | A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma | NCT01432353 | Phase I | Genentech Inc / Roche |
RG-7598 (DFRF 4539A) also know as RG7598 or RG 7598) is an antibody-drug conjugate in which a monoclonal antibody is linked to MMAE.
Last Editorial Review: July 17, 2016
